SOX2 enhances the migration and invasion of ovarian cancer cells via Src kinase

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ovarian cancer is a leading cause of cancer death in women.
• Novel molecular targets are crucial for improving patient outcomes.
• SOX2's role in ovarian cancer remains largely uncharacterized.

Purpose of the Study:

• To investigate the expression and function of SOX2 in serous ovarian carcinoma (SOC).
• To identify molecular mechanisms underlying SOX2's role in SOC progression.

Main Methods:

• Immunohistochemistry was used to assess SOX2 expression in 64 human SOC tissues and paired metastatic specimens.
• Functional assays were performed to evaluate the effects of SOX2 overexpression on SOC cell proliferation, migration, invasion, and adhesion.
• Target validation was conducted to identify downstream molecules regulated by SOX2.

Main Results:

• SOX2 expression was significantly lower in primary SOC tumors compared to metastatic lesions.
• SOX2 overexpression enhanced SOC cell proliferation, migration, and invasion while reducing adhesion.
• Src kinase was identified as a direct target of SOX2, mediating its effects on cell migration and invasion.

Conclusions:

• SOX2 plays a critical role in the progression and metastasis of serous ovarian carcinoma.
• SOX2 promotes SOC cell migration and invasion, potentially through the regulation of Src kinase.
• Targeting SOX2 or its downstream pathways may offer novel therapeutic strategies for ovarian cancer.